Page 30 - Technical Analysis

Trading strategies for Nifty Energy, MNCs, Commodities indices

According to Ravi Nathani, an independent technical analyst, all the three indices are presently displaying a bullish trend on charts.

Zomato, Paytm: New-age stocks hit multi-month highs; is there more upside?

New-age companies may rise up to 29 per cent in the forthcoming seasons as market sentiment improves amid record-breaking run in benchmark indies

Jio Financial listing: NBFC stocks must cross key hurdles to resume rally

Listed NBFC stocks are currently facing selling pressure at higher levels, show technical charts

Nifty Pharma, Realty near key resistance levels; Time to be cautious

According to Ravi Nathani, an independent technical analyst, the Nifty Pharma index needs to clear hurdle at 14,150; whereas, the Realty index may show signs of correction by the month-end.

Suzlon, Mazagon Dock: 75% of Nifty SmallCap stocks trade firm above 200-DMA

Overall trend - the Nifty Small cap index continues to remain highly robust, with an intend to reach a new historic high.

Bull-run resumes: Nifty to hit 21,000; Sensex may test 73K in August

The range breakout in both the indices have triggered fresh upside

Infy, TechM: Nifty IT index scales 4-month high, sets eye on 52-week peak

Selective IT stocks may rise up to 22% in the upcoming sessions, as per their technical charts

Suzlon, BSE: 5 Nifty 500 stocks gained over 15% in July, expect more upside

Technically, when any stocks crosses crucial hurdles and witnesses accumulation at key supports, the trend is expected to witness robust upside ahead.

TCS may hit Rs 4,000-mark on Q1 boost; HCL Tech could dip to Rs 1,000 level

Once the range of Rs 3,380 to Rs 3,350 is conquered, TCS shares are set to hit a new historic peak. HCL Tech, meanwhile, may slip under Rs 1,000 if it fails to hold the 200-DMA

Nifty Auto in overbought zone; Bullish trend for Pharma index may weaken

The RSI for Nifty Pharma shows a pattern of lower highs and lower lows on the near-term charts; Nifty Auto is in the overbought zone and could see a potential correction

Bears grip Delta Corp on highest ever volume, Nazara must hold 200-DMA

Delta Corp needs to cross the 200-DMA to regain the momentum, while Nazara Technologies must hold the 200-DMA as a support.

HAL, Mazagon Dock: Defence stocks may see up to 10% upside on robust charts

Defence related stocks continue to trade in overbought territory, as momentum sees elevated sentiment.

PFC, Sanghvi Movers, Bajaj twins: Trading strategies for buzzing stocks

These 5 buzzing stocks may rise up to 15% in the coming sessions

Arvind, Raymond: Textile stocks with land bank may rise up to 16%

Selective textile stocks are developing robust chart structures

RIL eyes new all-time high, Golden Cross breakout aims at Rs 3,000

The counter may struggle to cross Rs 2,800-mark, which appears to be the next hurdle, but the current momentum is not suggesting any weakness.

3 tyre stocks hit new highs on breakout; charts show up to 21% upside ahead

Selective tyre stocks are displaying resilient chart structures, poised to scale higher levels from a medium-term perspective.

Bharat Forge: Check why a bull-spread strategy is suitable for this stock

Buy Bharat Forge 860 CALL at Rs 21.25 & simultaneously sell 900 CALL at Rs 9.25 of the July series, suggests Nandish Shah, Sr. derivatives & technical research analyst of HDFC Securities

Bias for Nifty Energy index bullish in near-term; buy near support levels

Ravi Nathani, independent market analyst shares his trading strategies for Nifty Energy, and Nifty Commodities indices

Only 93 Nifty 500 stocks trade in overbought territory, more upside likely

Market participants closely monitor the RSI to determine the strength based on 70 and 30 values. This assists in identifying instruments that are supposedly experiencing increased buying or selling.

Nifty Metal, Pharma indices exhibit range-bound moves; wait for breakout

Ravi Nathani, independent market analyst shares his trading strategies for Nifty Metal and Nifty Pharma indices; check out